ERBB2 and breast carcinoma: Unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) is the most notoriously aggressive breast cancer type with poor outcomes over the past decade, which lacks expression of progesterone, Her2/Neu and estrogen receptors [1, 2].